Volume 23, Number 7—July 2017
CME ACTIVITY - Research
Risk Factors for Legionella longbeachae Legionnaires’ Disease, New Zealand
Table 2
Health conditions | Case-patients, no. (%) | Controls, no. (%) | OR (95% CI) |
---|---|---|---|
Preexisting health conditions | |||
Cardiac disease | 8 (26) | 35 (20) | 1.2 (0.47–3.0) |
Respiratory disease | 10 (32) | 35 (20) | 2.1 (0.87–4.9) |
Asthma | 8 (26) | 28 (16) | 1.9 (0.76–4.9) |
COPD | 5 (16) | 9 (5) | 4.2 (1.2–14.7) |
Diabetes | 5 (16) | 12 (7) | 2.8 (0.88–9.0) |
Immunosuppression |
6 (19) |
16 (9) |
2.7 (0.91–7.9) |
Smoking | |||
Current smoker | 4 (13) | 9 (5) | 2.4 (0.66–8.5) |
Ever smoked |
19 (61) |
63 (37) |
2.6 (1.2–5.7) |
Smoking period† | |||
Never smoked | 12 (39) | 109 (65) | 1.0 |
Smoked <20 y | 5 (16) | 26 (16) | 1.6 (0.5–5.1) |
Smoked 20 y to <40 y | 4 (13) | 17 (10) | 2.3 (0.6–8.0) |
Smoked >40 y | 10 (32) | 15 (9) | 5.6 (2.0–16.0) |
*COPD, chronic obstructive pulmonary disease; OR, odds ratio.
†Length of time smoking could not be determined for 5 control respondents. Percentages are given for those in which length of time smoking was known.
1These authors contributed equally to this article.
Page created: June 15, 2017
Page updated: June 15, 2017
Page reviewed: June 15, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.